HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity

FASEB Journal

Volumn 14, Issue 11, 2000, Pages 1629-1640

  Trusolino, L ^a   Cavassa, S ^a   Angelini, P ^a   Ando, M ^a   Bertotti, A ^a   Comoglio, P M ^a   Boccaccio, C ^a  

^a Cure of Cancer   (Italy)

Author keywords

Adhesion; Growth factors; Integrin activation; MET; Tyrosine kinase receptors

Indexed keywords

ACTIN; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; LAMININ; PROTEINASE; SCATTER FACTOR; TYROSINE KINASE RECEPTOR; VITRONECTIN;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL INVASION; CELL MIGRATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AVES; CERTHIA BRACHYDACTYLA; DENDROCOPOS MAJOR; DENDROCOPOS MINOR; FRINGILLA COELEBS; REGULUS REGULUS; SITTA EUROPAEA; STURNUS VULGARIS;

EID: 0033870609     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.99-0844com     Document Type: Article

References (59)

1. Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors
2. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
3. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor
4. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP
5. The tyrosine kinase receptors Ron and Sea control 'scattering' and morphogenesis of liver progenitor cells in vitro
6. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
7. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
8. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas
9. Activating mutations for the met tyrosine kinase receptor in human cancer
10. Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth
11. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas
12. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer
13. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit
14. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas
15. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation
16. Role of morphogenetic factors in metastasis of mammary carcinoma cells
17. The mutationally activated Met receptor mediates motility and metastasis
18. A mulfifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
19. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
20. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis
21. Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility
22. A point mutation in the MET oncogene abrogates metastasis without affecting transformation
23. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras
24. Regulation of scatter factor/hepatocyte growth factor responses by Ras. Rac, and Rho in MDCK cells
25. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase
26. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly
27. Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis
28. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells
29. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network
30. Epidermal growth factor (EGF)- and scatter factor/hepatocyte growth factor (SF/HGF)- mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9
31. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors
32. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
33. A rapid in vitro assay for quantitating the invasive potential of tumor cells
34. Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: Implications for tumor invasion
35. Polarized integrin mediates human keratinocyte adhesion to basal lamina
36. Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: Possible quantitative relationship
37. The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures
38. The nuclear matrix: Three-dimensional architecture and protein composition
39. Epithelial cytoskeletal framework and nuclear matrix-intermediate filament scaffold: Three-dimensional organization and protein composition
40. Protein Kinase C-dependent mobilization of the alpha6 beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells
41. Cadherins in cancer: Implications for invasion and metastasis
42. Adherens junction proteins in tumour progression
43. Adhesion molecules in cancer: The role of integrins
44. Anchorage-dependent cell cycle progression
45. Disruption of epithelial cell-matrix interactions induces apoptosis
46. Integrins: Versatility, modulation, and signaling in cell adhesion
47. Ligands 'activate' integrin alpha IIb beta 3 (platelet GPIIb-IIIa)
48. The dynamic regulation of integrin adhesiveness
49. A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18
50. Alpha 4 beta 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand
51. Regulation of the fibronectin receptor affinity by divalent cations
52. Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function
53. A high affinity conformational state on VLA integrin heterodimers induced by an anti-beta I chain monoclonal anti-body
54. Transmembrane molecular assemblies in cell-extracellular matrix interactions
55. Integrin cytoplasmic domains: Mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling
56. Molecular mechanisms for focal adhesion assembly through regulation of protein-protein interactions
57. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase
58. Hepatocyte growth factor is a pleiotropic factor protecting epithelial cells from apoptosis
59. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes